TAG:
molecular tests
Genome Sequencing Promises to be Disruptive
By R. Lewis Dark | From the Volume XV No. 14 – October 20, 2008 Issue
EVERYONE SHOULD CAREFULLY READ OUR LEAD STORY ON THE FACING PAGE. Titled “Rapid Gene Sequencing Predicted by Mid-2009,” it is a revealing look at the declaration of California-based Complete Genetics that, in less than eight months, it will begin delivering full human genome sequ…
Hospital Labs Have New Options for Molecular Dx
By Robert Michel | From the Volume XV No. 14 – October 20, 2008 Issue
CEO SUMMARY: Laboratories that offer molecular assays continue to see strong growth in four areas: oncology, hematopathology, infectious diseases, and personalized medicine. Further, a new generation of molecular testing systems and analyzers is coming to market which will make it easier …
DeVry University, Retail Walk-In Clinics, NeoGenomics, Clarient, Clinical Lab Partners, Patient ID Theft
By Robert Michel | From the Volume XV No. 13 – September 29, 2008 Issue
MED TECH SHORTAGE CAUSES DEVRY UNIVERSITY TO OFFER MT DEGREE IN RESPONSE TO THE GROWING SHORTAGE of skilled lab scientists and medical technologists, DeVry University of Phoenix, Arizona, is offering a new bachelor’s degree program in Clinical Laboratory Science (…
Hospital Lab Evolves Into A Consultative Resource
By Robert Michel | From the Volume XV No. 5 – April 14, 2008 Issue
CEO SUMMARY: Every laboratory recognizes it has the knowledge and expertise to become more of a consultative resource to its referring physicians. At 248-bed J.T. Mather Hospital in Port Jefferson, New York, the laboratory director took advantage of administration’s interest in improving …
Powerful Trends Reshaping Anatomic Path Profession
By Robert Michel | From the Volume XV No. 2 – February 11, 2008 Issue
CEO SUMMARY: THE DARK REPORT presents its newest biannual review of macro trends reshaping the anatomic pathology profession. These macro trends reveal a profession undergoing change and transformation on multiple fronts. New competitors are crowding into the market, payers and accreditin…
Inverness Buys Biosite, Has New Venture with P&G
By Robert Michel | From the Volume XIV No. 8 – June 4, 2007 Issue
CEO SUMMARY: On the same day that Inverness Medical Innovations announced that it would acquire Biosite, thus beating out Beckman Coulter in the bidding war for Biosite, Inverness also announced that it had entered into a joint venture with Procter & Gamble. Together, the two companie…
Emerging Global Trends in How Labs Are Using “Distributed Computing”
By Robert Michel | From the Volume XIV No. 7 – May 14, 2007 Issue
“In several different countries, laboratories already use ‘distributed computing’, in the form of a single LIS data center that provides informatics services to as many as 25 laboratories in a region. The trend is to increase interoperability and portability of the i…
Why Labs Will Increase their Use of Middleware and Informatics
By Robert Michel | From the Volume XIV No. 6 – April 23, 2007 Issue
“Across the globe, laboratories face similar and significant challenges in how they use information technology and middleware to solve problems.” —Jacques Baudin, Executive Vice President, Technidata America Medical Software CEO SUMMARY: Midd…
Bringing You the REAL Story behind the Story!
By R. Lewis Dark | From the Volume XIV No. 5 – April 2, 2007 Issue
HOW MUCH DO YOU TRUST THE NEWSPAPERS AND OTHER MEDIA you read to give you the right story, with the right analysis? If you are like me, you are regularly disappointed that the nation’s journalists are too quick to report the obvious—while often missing the important nuances that bring out the tru…
Newspaper Reports Miss on Molecular Technology
By Robert Michel | From the Volume XIV No. 5 – April 2, 2007 Issue
CEO SUMMARY: In reporting on a suspected outbreak of whooping cough (Bordetella pertussis), a national newspaper suggested administrators at Dartmouth Hitchcock Medical Center had placed too much faith in molecular testing. In this exclusive interview, Dartmouth’s Director of Molecular …
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized